Weight Loss Drug Belviq (Locaserin) May Cause Cancer

The United States Food & Drug Administration (FDA) is warning consumers that the prescription weight loss drug Belviq may cause cancer. A clinical trial showed an increased risk of cancer — and Eisai Inc., the manufacturer, has requested to voluntarily withdraw the drug from the market.

Belviq was approved by the FDA in 2012 to help overweight and obese adults lose weight. Belviq works by increasing feelings of fullness. Eisai, Inc., conducted a randomized double-blind, placebo-controlled clinical trial to evaluate the risk of heart-related problems. The study showed that approximately 12,000 participants who took the medication over a period of 5 years, more patients taking Belviq (Locaserin) were diagnosed with cancer. Pancreatic, colorectal and lung cancer occurred more frequently among patients taking Belviq.  

If you or a loved one has suffered from cancer from taking Belviq, please call the experts at Inserra Kelley Sewell to see whether you might be entitled to compensation.  

You may also be interested in: Belviq (lorcaserin) Lawsuit Nebraska Eastern Iowa

Medtronic Recalls MiniMed Insulin Pumps After Many Injuries and One Death

Medtronic is recalling over 322,000 if its insulin pumps because of a missing or faulty component that can lead to over or under delivery of insulin.  This can cause hypoglycemia or hyperglycemia in diabetics. The FDA has initiated a Class I Recall which means there may be significant or immediate danger of death or other serious injury from the product being recalled.

There have been over 26,000 complaints about the devices malfunctioning and one confirmed death.  Over 2,175 injuries to diabetics that have used the MiniMed pump have occurred since the recall.

The recalled products are:

  • MiniMed 600 Series Insulin Pumps
  • Model 630G(MMT-1715) – all lots before October 2019
  • Model 670G (MMT-1780) – all lots before August 2019

Consumers who have questions about this recall should call the 24-hour Medtronic hotline at 800-646-4633.  

If you or a loved one has suffered from symptoms and/or injuries from using the Medtronic MiniMed insulin pumps, please call the experts at Inserra Kelley Sewell to see whether you might be entitled to compensation.